Thrombosis risk stratification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
==Risk stratification==
It is defined as the ability to predict outcomes from a given intervention by arranging patients according to the severity of their illness.


==Risk factors==
==Risk factors==
{|style="background:LightSkyBlue" border="1"
*'''General'''
|-
**Older age
|Age
**Female gender
|(continuous)
**[[Smoking]]
|-
**[[Obesity]]
|Body mass index
**[[Pregnancy]]
|(continuous)
**Immobilisation
|-
|Smoking status
|(non-smoker; ex-smoker; light, moderate, or heavy smoker)
|-
|Townsend deprivation score
|(continuous)
|-
|Varicose veins
|(yes/no)
|-
|Congestive cardiac failure
|(yes/no)
|-
|Rheumatoid arthritis
|(yes/no)
|-
|Chronic renal disease
|(yes/no)
|-
|Inflammatory bowel disease
|(yes/no)
|-
|Cancer
|(lung, gastrointestinal, pancreas, renal, breast, prostate, other)
|-
|Recent hospital admission
|yes/no)
|-
|Recent hip fracture or hip surgery (or both)
|yes/no)
|-
|Current use of antipsychotic drugs
|(none, atypical, typical)
|-
|Current use of tamoxifen
|(yes/no)
|-
|Current use of hormone replacement therapy
|(none, equine or non-equine hormone replacement therapy)
|-
|Use of antiplatelets
|(yes/no)
|-
|Cardiovascular disease
|(stroke, transient ischaemic attack, or coronary heart disease)
|-
|Atrial fibrillation
|(yes/no)
|-
|Asthma
|(yes/no)
|-
|Chronic obstructive pulmonary disease
|(yes/no)
|-
|Family history of venous thromboembolism
|(yes/no)
|}


*'''Medical'''
**Surgery
**[[Trauma]]
**[[Oral contraceptive]] use
**[[Varicose vein]]s
**[[Malignancy]]
**Kidney disorders
**[[Lupus anticoagulant]]
**[[Paroxysmal nocturnal hemoglobinuria]]
**[[Inflammatory bowel disease]]
**[[Thromboangiitis obliterans]]
**[[Disseminated intravascular coagulation]]
*'''Familial'''
**[[Antithrombin|Antithrombin III deficiency]]
**[[Protein C deficiency]]/[[Protein S deficiency]]
**APC resistance ([[Factor V Leiden]])
**Dysfibrogenemia
**Hypoplasminogenemia
**Familial homocysteinemia
==Source==
==Source==
http://www.bmj.com/content/343/bmj.d4656.full
http://www.bmj.com/content/343/bmj.d4656.full

Revision as of 02:18, 4 September 2011

Thrombosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Classification

Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial
Venous

Differentiating Thrombosis from other Diseases

Arterial
Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications

Prevention

Thrombosis risk stratification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombosis risk stratification

CDC onThrombosis risk stratification

Thrombosis risk stratification in the news

Blogs on Thrombosis risk stratification

to Hospitals Treating Thrombosis risk stratification

Risk calculators and risk factors for Thrombosis risk stratification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

Risk factors

Source

http://www.bmj.com/content/343/bmj.d4656.full

Template:SIB

cs:Trombóza de:Thrombose eo:Trombozo it:Trombosi he:תרומבוס ms:Trombotik nl:Trombose fi:Verihiutale

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Thrombosis_risk_stratification&oldid=595849"